Telangana Anti-Narcotics Bureau Seals Alprazolam Manufacturing Unit

Hyderabad: Gosukonda Anji Reddy, 41, owner of Chandra Reddy Garden, and Gummadidala Swimming pool, in Gummadidala, and Kyasaram Rakesh, 36, a realtor, were arrested after a contraband manufacturing lab was discovered on their premises in Sangareddy.

The Telangana Anti-Narcotics Bureau (TGANB) officials seized 2.6 kilograms of contraband along with the manufacturing lab and the equipment used. About 20 kilograms of stage-1 intermediate product, 10 kilograms of stage-2 intermediate produce, 350 litres of mixed solution, 35 kilograms of hexamethyl antihistamine, 16 litres of acetic acid, one barrel of ammonium carbonate, and 90 kilograms of phosphorous penta sulphide were also seized.

According to officials, the two arrested were suppliers to a network of drugs comprising Prabhakar Goud and Sai Kumar, who were previously booked under the Narcotic Drugs and Psychotropic Substances (NDPS) Act for illegally manufacturing and selling alprazolam to toddy sellers for spiking the drink.

Sai Kumar Goud and K. Rakesh previously worked in various pharma laboratories and acquired knowledge of the chemicals and manufacturing process of alprazolam. Owing to the demand for adulterated toddy, they started manufacturing alprazolam illegally, the officials explained.

Five factories manufacturing alprazolam have been unearthed in the last one year including at Nagarkurnool DRI, Jinnaram, Cherlapally, Vijayawada and Fisalwadi – while the drug is also being supplied from Pune, Indore, Ratlam and Delhi.

A case has been booked under Section 8(c) r/w 21(c), 22(c), 29 of the NDPS Act-1985.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records